Stefan Hartle,Stephane Leclair,Amgad Shebl,Stefan Steidl
申请号：
US15880726
公开号：
US20180230208A1
申请日:
2018.01.26
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention provides anti-GM-CSF antibodies for use in the treatment of rheumatoid arthritis. Anti-GM-CSF antibodies, in particular MOR103, are administered to patients suffering from rheumatoid arthritis at dosages that are beneficial in a clinical setting.
